Skip to Main Content

Current Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source.


The Vera and Joseph Dresner Foundation MDS Research Fund
The fund will facilitate the advancement of innovative basic science, translational or clinical research to advance the understanding and treatment of Myelodysplastic Syndromes (MDS) and related blood disorders (such as MDS/myeloproliferative neoplasms (MPN) overlap syndromes, secondary acute myeloid leukemia following MDS, idiopathic cytopenia of undetermined significance (ICUS), or clonal hematopoiesis of indeterminate potential (CHIP).

The foundation will consider proposals from individuals at university, college, hospital, or laboratory institutions for support of research in MDS or related disorders in two types:
- Early Career Awards
- Established Investigator Awards

Letter of Intent (LOI) Deadline: LOIs are accepted on a rolling basis.
Learn More>>

Fast Funding for COVID-19 Science

If you are a scientist at an academic institution currently working on a COVID-19 related project and in need of funding, we invite you to apply for a Fast Grant.

Deadline: Fast Grant decisions are made in under 48 hours. Apply Now!

Apply for a Fast Funding grant now>>

Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01)

The purpose of this FOA is to solicit applications to develop, adapt, and test individual-, community- or multilevel interventions to address modifiable risk factors for cancer in rural populations.

Application Deadline: March 15, 2021

Learn more about the rural population award>>

The Blavatnik Fellowship in Life Science Entrepreneurship

This Blavatnik Fellowship is designed to foster entrepreneurial skills in the life sciences, linking emerging business leaders with breakthrough innovations from across Yale University, and has spun out many successful professionals.

Application Deadline: March 15, 2021

ACS/NESS Health Policy and Management Scholarship

This scholarship supports attendance and participation in the "Executive Leadership Program in Health Policy and Management" and is open to shared U.S. members in good standing between the ages of 30-60.

Application Deadline: March 17, 2021

Department of Defense (DoD) Breast Cancer Awards

Breast Cancer Alliance Exceptional Project Grants

The BCA invites clinical doctors and research scientists at any stage of their careers whose primary focus is breast cancer to apply for an Exceptional Project Grant. This award recognizes creative, unique, and innovative research and is open to applicants throughout the US.

Internal LOI Deadline: March 17, 2021

V Foundation Pediatric Scholar and Translational Grant

The Pediatric V Scholar Award supports young tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. Translational projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms. Yale may nominate ONE nominee for a V pediatric grant.

Internal LOI Deadline: March 17, 2021

Small Business Transition Grant for Early Career Scientists

This FOA aims to support early career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses.

Application Deadline: March 24, 2021

DoD Lung Cancer Research Program Funding Opportunities

The FY21 Defense Appropriations Act is anticipated to provide funding to the Department of Defense LCRP to support innovative, high-impact lung cancer research.

Concept Award - LOI Due: March 31, 2021
Career Development Award - LOI Due: March 31, 2021
Investigator-Initiated Translational Research Award - Pre-proposal Due: May 5, 2021
Clinical Translational Research Partnership Award - LOI Due: July 14, 2021

2021 SITC Fellowships

SITC is offering four Fellowships, totaling $450,000 in funding. These fellowships are open to all early career investigators, domestic and international from academia and government. Please help us spread the word about these incredible opportunities.
  • SITC–Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship (two years, $200,000)
  • SITC–Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship (one year, $100,000)
  • SITC–AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship (one year, $100,000)
  • SITC–Nektar Therapeutics Equity and Inclusion in Cancer Immunotherapy Fellowship (one year, $50,000)

Application Deadline: April 2, 2021

NIH RFI: Inviting Comments and Suggestions to Advance and Strengthen Racial Equity, Diversity, and Inclusion in Biomedical Research and Advance Health Disparities and Health Equity Research

This RFI invites feedback on the approaches the NIH can take to advance racial equity, diversity, and inclusion within all facets of the biomedical research workforce and expand research to eliminate or lessen health disparities and inequities.

Responses Due: April 9, 2021

NCCN Request for Proposals (RFP): Phase I/II Clinical and/or Correlative Studies of the panHER Inhibitor Neratinib in the Treatment of Breast, Gastrointestinal, Lung, and Neurological Cancers

This RFP is to support NCCN Member Institution faculty for the performance of clinical and correlative studies to further evaluate the effectiveness of neratinib in the treatment of breast, gastrointestinal (GI), lung and neurological cancers.

Application Deadline: April 19, 2021

Cancer Grand Challenges Program

The NCI and Cancer Research UK (CRUK) are partnering to fund the Cancer Grand Challenges program. Cancer Grand Challenges will fund novel ideas by multidisciplinary research teams from around the world that offer the potential to advance bold cancer research and improve outcomes for people affected by cancer. These nine challenges are aimed at solving complex problems in cancer research, which, if solved, could have a transformative impact towards progress.

Application Deadline: April 22, 2021

NCCN/AstraZeneca Initiative RFP in Patients with Early Stage Non-Small Cell Lung Cancer (NSCLC)

The intent of this RFP is to encourage NCCN Member Institutions to submit letters of intent (LOIs) describing concepts and ideas for developing, implementing and evaluating healthcare provider performance and/or healthcare quality improvement initiatives to improve patient care and outcomes in early-stage NSCLC.

Letter of Intent Deadline: May 3, 2021

The Cure Starts Now Foundation Research Grants

Research questions considered - Disease Impact: Does the study propose an intervention or clinical tool that will reduce the morbidity or mortality from or potentially find a cure for pediatric brain cancer? Innovation: Does the research study propose a novel approach or represent advancement in current treatment of pediatric brain cancer?

Application Deadline: June 1, 2021

Breast Cancer Alliance Young Investigator Grant

To encourage a commitment to breast cancer research, the BCA invites clinical doctors and research scientists whose primary focus is breast cancer and who are in the early stages of their careers to apply for funding for the Young Investigator Grant.

Internal LOI Deadline: June 1, 2021

Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program

The BMSF DCTCDP is a 2-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians underrepresented in medicine, or physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring.

Application Deadline: July 2, 2021

Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01)

This FOA supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries.

Application Deadline: June 2, 2021

Tobacco Regulatory Science (R01)

The purpose of this FOA is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health.

Application Deadline: July 14, 2021